METTL14 and acute myeloid leukemia: Mutations in writers (METTL3, METTL14, WTAP, RBM15) promote and maintain leukemogenesis in AML [74,75,76,77,78,79], whereas overexpression of the eraser FTO in AML cell lines also promoted proliferation and decreased apoptosis [80].